【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Causes of Ankylosing Spondylitis
06.3 Pathophysiology
06.4 Epidemiology
06.5 Diagnosis
06.6 Treatment and Management
06.6.1 Analgesics
06.6.2 Corticosteroids
06.6.3 DMARDs
06.6.4 Biologics
06.6.5 Physiotherapy
06.6.6 Surgery
06.7 Economic Burden
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08.Market Segmentation by Mechanism of Action
08.1 TNF Inhibitors
08.2 COX Inhibitors
08.3 Others
09.Market Segmentation by Type of Molecule
09.1 Biologics
09.2 Small Molecules
10.Market Segmentation by Route of Administration
10.1 Oral
10.2 Parenteral
11.Market Segmentation by Dosage Forms
11.1 Solid
11.2 Liquid
12.Geographical Segmentation
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Competitive Assessment of the Top Drugs for Ankylosing Spondylitis
20.2.2 Abbvie
20.2.3 Janssen Pharmaceuticals
20.2.4 Amgen
20.2.5 Pfizer
20.2.6 Merck
20.3 Other and Future Prominent Vendors
21.Pipeline Portfolio
22.Key Vendor Analysis
22.1 AbbVie Inc.
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Product Segmentation by Revenue 2013
22.1.4 Product Segmentation by Revenue 2012 and 2013
22.1.5 Sales by Geography
22.1.6 Business Strategy
22.1.7 Key Developments
22.1.8 SWOT Analysis
22.2 Amgen
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation by Revenue 2013
22.2.4 Product Portfolio by Revenue 2013
22.2.5 Business Segmentation by Revenue 2012 and 2013
22.2.6 Geographical Segmentation by Revenue 2013
22.2.7 Business Strategy
22.2.8 Recent Developments
22.2.9 SWOT Analysis
22.3 Janssen Pharmaceuticals
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Recent Developments
22.3.4 SWOT Analysis
22.4 Merck
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
22.5 Pfizer
22.5.1 Key Facts
22.5.2 Business Overview
22.5.3 Business Segmentation by Revenue 2013
22.5.4 Business Segmentation by Revenue 2012 and 2013
22.5.5 Geographical Segmentation by Revenue
22.5.6 Business Strategy
22.5.7 Key Developments
22.5.8 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global Ankylosing Spondylitis Market 2014-2019
Exhibit 3: Snapshot of Ankylosing Spondylitis
Exhibit 4: Diagnosis of Ankylosing Spondylitis
Exhibit 5: Treatment and Management of Ankylosing Spondylitis
Exhibit 6: Snapshot of the Economic Burden of Ankylosing Spondylitis
Exhibit 7: Snapshot of the Global Ankylosing Spondylitis Market
Exhibit 8: Global Ankylosing Spondylitis Market 2014-2019 (US$ million)
Exhibit 9: Drivers and Challenges of Global Ankylosing Spondylitis Market
Exhibit 10: Global Ankylosing Spondylitis Market Segmentation by Mechanism of Action
Exhibit 11: Global Ankylosing Spondylitis Market Segmentation by Mechanism of Action 2014
Exhibit 12: Global Ankylosing Spondylitis Market Segmentation by Type of Molecule
Exhibit 13: Global Ankylosing Spondylitis Market Segmentation by Type of Molecule 2014
Exhibit 14: Global Ankylosing Spondylitis Market Segmentation by Route of Administration
Exhibit 15: Global Ankylosing Spondylitis Market Segmentation by Route of Administration 2014
Exhibit 16: Global Ankylosing Spondylitis Market Segmentation by Dosage Forms
Exhibit 17: Global Ankylosing Spondylitis Market Segmentation by Dosage Forms 2014
Exhibit 18: Global Ankylosing Spondylitis Market by Geographical Segmentation 2014
Exhibit 19: Buying Criteria of the Global Ankylosing Spondylitis Market
Exhibit 20: Drivers and their Impact on the Key Customer Category of the Global Ankylosing Spondylitis Market
Exhibit 21: Drivers and Their Geography-wise Impact on the Global Ankylosing Spondylitis Market
Exhibit 22: YoY Sales Comparison of Top Drugs used for Ankylosing Spondylitis 2010-2013 (US$ million)
Exhibit 23: Revenue Share of the Top Drugs used for Ankylosing Spondylitis 2010-2013
Exhibit 24: Abbvie: Product Portfolio for Ankylosing Spondylitis
Exhibit 25: YoY Global Sales of Humira 2008-2013 (US$ million)
Exhibit 26: Janssen: Product Portfolio for Ankylosing Spondylitis
Exhibit 27: YoY Sales of Remicade 2005-2013 (US$ million)
Exhibit 28: YoY Sales of Simponi 2010-2013 (US$ million)
Exhibit 29: Amgen: Product Portfolio for Ankylosing Spondylitis
Exhibit 30: YoY Sales of Enbrel (In US and Canada) 2005-2013 (US$ million)
Exhibit 31: YoY Sales of Enbrel In US 2005-2013 (US$ million)
Exhibit 32: YoY Sales of Enbrel In Canada 2005-2013 (US$ million)
Exhibit 33: Region-wise Sales Comparison of Enbrel 2005-2013 (US$ million)
Exhibit 34: Pfizer: Product Portfolio for Ankylosing Spondylitis
Exhibit 35: YoY Sales of Enbrel (Outside US and Canada) 2009-2013 (US$ million)
Exhibit 36: YoY Sales of Enbrel (Outside US and Canada) 2008-2013 (US$ million)
Exhibit 37: Merck: Product Portfolio for Ankylosing Spondylitis
Exhibit 38: YoY Sales of Remicade 2005-2013 (US$ million)
Exhibit 39: YoY Sales of Simponi 2010-2013 (US$ million)
Exhibit 40: AbbVie Inc.: Product Segmentation by Revenue 2013
Exhibit 41: AbbVie Inc.: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 42: AbbVie Inc.: Sales by Geography 2013
Exhibit 43: Amgen: Business Segmentation by Revenue 2013
Exhibit 44: Amgen: Product Portfolio by Revenue 2013
Exhibit 45: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 46: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 47: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 48: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 49: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 50: Pfizer: Business Segmentation by Revenue 2013
Exhibit 51: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 52: Pfizer: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル:強直性脊椎炎(Ankylosing Spondylitis)治療薬の世界市場2015-2019■ 英文:Global Ankylosing Spondylitis Market 2015-2019
■ 発行日:2015年1月7日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5050
■ 調査対象地域:グローバル
- Dorchester Minerals, L.P.:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Dorchester Minerals, L.P. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Dorchester Minerals, L.P. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- カオリンの世界市場分析:用途別(紙、陶器、塗料、ガラス繊維およびゴム)、セグメント予測、-2020Global Kaolin Market is expected to reach USD 5.88 billion by 2020, according to a new study by Grand View Research, Inc. Growth of construction sector on account of industrialization in emerging economies including China, Brazil, India and Russia is expected to drive kaolin market demand. Kaolin is used in ceramics and concrete to increase whiteness and brightness of the base material. Growing fo …
- ポリカーボネート板の世界市場予測(~2023年)The polycarbonate sheets market is projected to reach USD 2.11 billion by 2023, at a CAGR of 4.5% from 2018 to 2023. The polycarbonate sheets market is projected to grow from USD 1.69 billion in 2018 to USD 2.11 billion by 2023, at a CAGR of 4.5% between 2018 and 2023. Factors such as increasing consumption of polycarbonate sheets in the automotive and construction industries due to effective char …
- 世界のスマート太陽光市場Smart solar is the advancement in the traditional solar energy system. This class of technology brings improved integration and forecasting, support and communication, control and maintenance, distribution, mitigation and planning capabilities in the delivery systems. The smart solar market research report provides in-depth study of the driving forces, restraints and challenges for this market. It …
- OLED照明の世界市場2015-2022A year ago the outlook for OLED lighting seemed to brighten a bit, anticipating that new capacity build-outs and continued development would enable higher outputs and lower costs, and finally start to unlock broad market demand. Unfortunately these efforts largely haven't panned out: LG Chem has pushed out its planned expansion, Konica Minolta did ramp but we believe with disappointing results so …
- 医療用セラミックスの世界市場:生体不活性セラミックス、生体活性セラミックス、合成吸収性セラミックスAbout Ceramics Ceramics exclusively developed for use in the medical field are termed as medical ceramics. The chemical and physical properties of the ceramics are attributed in such a way that they are compatible with the internal environment of body. Ceramics are mostly used as bone implants. Technavio’s analysts forecast the global medical ceramics market to grow at a CAGR of 7.06% during the p …
- ポリエチレン包装の世界市場2019-2023About this market Innovations in packaging to improve convenience is one of the major growth driver of the global polyethylene packaging market. Customer convenience has become a priority for most vendors operating in the global polyethylene packaging market. While many consumer goods packaging companies are planning to launch innovative products, most of these companies are focusing on new packag …
- 触覚技術(ハプティクス)の世界市場2016-2020About Haptics Technology Haptic technology deals with touch sensation while interacting with touchscreen devices such as smartphones, tablets, and infotainment systems through a tactile feedback technology. Touch sensations can be in the form of applied forces, motions, or vibrations and can be felt by users through devices. This stimulation enhances the user experience and can be used to create a …
- ハイパースペクトル撮像装置の世界市場The global hyperspectral imaging technologies market is estimated to grow at a CAGR of 12.0% during the forecast period of 2014 to 2019. Although the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the hyperspectral imaging technologies market, the Asian region is expected to grow at the fastest CAGR of 13.0% during the given forecast period. The growth of the hypers …
- 拡張期高血圧:治療薬のグローバル治験動向(2014年下半期)Diastolic Hypertension Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Diastolic Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Diastolic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diastolic Hypertension. It includes an overview of the trial numbers and …
- 耐糖能障害(Glucose Intolerance):グローバル臨床試験レビュー(2014年上半期)Glucose Intolerance Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Glucose Intolerance Global Clinical Trials Review, H1, 2014" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recru …
- 授乳用品の世界市場分析The global breastfeeding accessories market is anticipated to reach USD 2.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to exhibit lucrative growth during the forecast period, owing to rising consumer awareness about breastfeeding accessories coupled with decreasing infant mortality rates. Worldwide declining infant mortality rate is expected to f …
- 世界のエピネフリン自動注入装置市場動向(2012-2016)TechNavio's analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of allergies. The Global Epinephrine Auto-injector market has also been witnessing the development of chlorofluorocarbon-free epinephrine auto-injector inhalers. However, the ad …
- Oil India Limited:石油・ガスバリューチェーン分析レポート2013Oil India Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Oil India Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Oil India Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the …
- 家電用耐擦傷性ガラス・コーティング剤の世界市場2019-2023About this market The increasing demand for innovative consumer electronics, especially smartphones and tablets, is leading to rapid changes in the market landscape. Smartphones and tablets have become inevitable, and their everyday use poses a risk of damage. Therefore, key manufacturers are focusing on developing multifunctional products. The multiple benefits of scratch-resistant glass and coat …